Literature DB >> 7675939

Hypothalamic-pituitary-gonadal axis in depressed premenopausal women: elevated blood testosterone concentrations compared to normal controls.

W Baischer1, G Koinig, B Hartmann, J Huber, G Langer.   

Abstract

To assess the function of the hypothalamic-pituitary-gonadal (HPG) axis in major depression, a multihormonal study was carried out in 20 depressed premenopausal women. Serum concentrations of LH, FSH, estradiol, progesterone, testosterone, and GnRH-stimulated LH and FSH were measured before initiation of treatment (on the first day after menstruation) and during clomipramine treatment (same time one menstrual cycle later). Significantly higher blood concentrations of testosterone were found in untreated patients compared to normal controls. Furthermore, there was a significant negative correlation between Hamilton depression scores and estradiol concentrations of patients. The efficacy of clomipramine treatment was not related to hormonal parameters.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7675939     DOI: 10.1016/0306-4530(94)00081-k

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  20 in total

1.  Longitudinal change in reproductive hormones and depressive symptoms across the menopausal transition: results from the Study of Women's Health Across the Nation (SWAN).

Authors:  Joyce T Bromberger; Laura L Schott; Howard M Kravitz; Maryfran Sowers; Nancy E Avis; Ellen B Gold; John F Randolph; Karen A Matthews
Journal:  Arch Gen Psychiatry       Date:  2010-06

2.  Stress response circuitry hypoactivation related to hormonal dysfunction in women with major depression.

Authors:  Laura M Holsen; Sarah B Spaeth; Jong-Hwan Lee; Lauren A Ogden; Anne Klibanski; Susan Whitfield-Gabrieli; Jill M Goldstein
Journal:  J Affect Disord       Date:  2010-12-22       Impact factor: 4.839

3.  Depression symptoms and body dissatisfaction association among polycystic ovary syndrome women.

Authors:  Lisa M Pastore; James T Patrie; Wendy L Morris; Parchayi Dalal; Megan J Bray
Journal:  J Psychosom Res       Date:  2011-03-23       Impact factor: 3.006

Review 4.  Disruption of fetal hormonal programming (prenatal stress) implicates shared risk for sex differences in depression and cardiovascular disease.

Authors:  J M Goldstein; R J Handa; S A Tobet
Journal:  Front Neuroendocrinol       Date:  2013-12-16       Impact factor: 8.606

5.  17β-estradiol differentially regulates stress circuitry activity in healthy and depressed women.

Authors:  Emily G Jacobs; Laura M Holsen; Katie Lancaster; Nikos Makris; Sue Whitfield-Gabrieli; Anne Remington; Blair Weiss; Stephen Buka; Anne Klibanski; Jill M Goldstein
Journal:  Neuropsychopharmacology       Date:  2014-08-12       Impact factor: 7.853

6.  Preconception stress and the secondary sex ratio in a population-based preconception cohort.

Authors:  Jisuk Bae; Courtney D Lynch; Sungduk Kim; Rajeshwari Sundaram; Katherine J Sapra; Germaine M Buck Louis
Journal:  Fertil Steril       Date:  2017-01-16       Impact factor: 7.329

7.  Interactions of sexual activity, gender, and depression with immunity.

Authors:  Tierney Lorenz; Sari van Anders
Journal:  J Sex Med       Date:  2013-02-28       Impact factor: 3.802

Review 8.  Dynamic regulation of estrogen receptor-alpha gene expression in the brain: a role for promoter methylation?

Authors:  Melinda E Wilson; Jenne M Westberry; Amanda K Prewitt
Journal:  Front Neuroendocrinol       Date:  2008-03-13       Impact factor: 8.606

9.  Association of testosterone levels and future suicide attempts in females with bipolar disorder.

Authors:  Leo Sher; Michael F Grunebaum; Gregory M Sullivan; Ainsley K Burke; Thomas B Cooper; J John Mann; Maria A Oquendo
Journal:  J Affect Disord       Date:  2014-05-05       Impact factor: 4.839

Review 10.  The effects of early life stress on motivated behaviors: A role for gonadal hormones.

Authors:  Samantha R Eck; Debra A Bangasser
Journal:  Neurosci Biobehav Rev       Date:  2020-10-03       Impact factor: 8.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.